An analysis of two large surveys published in February in Menopause, the journal of the North American Menopause Society, reported that 28% to 68% of women using hormones at menopause take compounded, so-called “bioidentical” hormones. The analysis further revealed that women do not understand that compounded hormone products, which are not clinically tested or approved by the US Food and Drug Administration (FDA), carry innate risks.
FAQ: Are Compounded Bioidentical Hormones Safe for HRT?
